NCT03146767

Brief Summary

The staircase phenomenon could have repercussions on the onset and recovery time following administration of a neuromuscular blocking agent. The investigators aim to assess the magnitude of the staircase phenomenon and its impact on various aspects of neuromuscular blockade with a randomized controlled double blind trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2013

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

April 25, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 10, 2017

Completed
Last Updated

May 10, 2017

Status Verified

May 1, 2017

Enrollment Period

1.1 years

First QC Date

April 25, 2017

Last Update Submit

May 5, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference in Block Onset time difference (seconds)

    Onset time is the time between Train of Four (TOF) at the moment of injection of neuromuscular blocking drug and the minimum value reached (onset of neuromuscular block)

    rom 0 seconds up to 240 seconds after neuromuscular block administration at the beginning of surgery. Time frame is the duration of general anesthesia before, during and after surgery (up to 4 hours).

Secondary Outcomes (11)

  • Difference in time until recovery of a TOF ratio (TOFr) of 0.9

    From administration of neuromuscular blocking drug until spontaneous reversal (up to 4 hours). Time frame is the duration of general anesthesia before, during and after surgery (up to 4 hours).

  • Difference in TOFr 0.9 Normalized

    From administration of neuromuscular blocking drug until spontaneous reversal at this specified point (up to 4 hours). Time frame is the duration of general anesthesia before, during and after surgery (up to 4 hours).

  • Difference in time until recovery of 25% of maximum twitch height ot T1 stimulus (DUR25)

    From administration of neuromuscular blocking drug until spontaneous reversal at this specified point (up to 4 hours). Time frame is the duration of general anesthesia before, during and after surgery.(up to 4 hours)

  • Time between 25% and 75% of maximum twitch height recovery of T1 stimulus

    From administration of neuromuscular blocking drug until spontaneous reversal (up to 4 hours). Time frame is the duration of general anesthesia before, during and after surgery (up to 4 hours).

  • Difference between first stimulus of Train-of-Four ratio at baseline

    Single measurement of muscle response after calibration procedure at the beginning of data recording after randomization. It is not a time-to-event variable

  • +6 more secondary outcomes

Study Arms (2)

Tetanic Group

EXPERIMENTAL

A Tetanic stimulation (Tetanus stabilization of baseline) is administered to the monitorized arm before calibrating the neuromuscular block monitor. Then Train-of-four (TOF) stimuli are administered every 20 seconds for 20 minutes.

Device: Tetanus stabilization of baseline

Control Group

NO INTERVENTION

Conventional monitor baseline stabilization: Train-of-four stimuli are administered every 20 seconds for 20 minutes

Interventions

Administering a Tetanic stimulus before baseline stabilization shortens the stabilization period of baseline of a neuromuscular block monitor. This acts on the baseline value

Tetanic Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA (American Society of Anesthesiology surgical risk scale) grade I - II
  • Surgery not involving airway performed under general anaesthesia with neuromuscular blocker

You may not qualify if:

  • Pregnancy
  • BMI (Body Mass Idex) \> 35 Kg/m2
  • Anticipated difficult airway
  • Chronic kidney or hepatic failure
  • Neuromuscular disease
  • Medication that has known interactions with neuromuscular blockers
  • Hemodynamic failure
  • Anticipated large blood loss

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario La Fe

Valencia, Spain

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiology Consultant

Study Record Dates

First Submitted

April 25, 2017

First Posted

May 10, 2017

Study Start

February 1, 2013

Primary Completion

March 1, 2014

Study Completion

March 1, 2014

Last Updated

May 10, 2017

Record last verified: 2017-05

Locations